REGN Annual Gross Margin
86.16%
-1.02%-1.17%
31 December 2023
Summary:
As of January 20, 2025, REGN annual gross profit margin is 86.16%, with the most recent change of -1.02% (-1.17%) on December 31, 2023. During the last 3 years, it has fallen by -0.66% (-0.76%). REGN annual gross margin is now -13.50% below its all-time high of 99.61%, reached on December 31, 2008.REGN Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Quarterly Gross Margin
86.80%
+0.34%+0.39%
30 September 2024
Summary:
As of January 20, 2025, REGN quarterly gross profit margin is 86.80%, with the most recent change of +0.34% (+0.39%) on September 30, 2024. Over the past year, it has increased by +1.85% (+2.18%). REGN quarterly gross margin is now -12.90% below its all-time high of 99.66%, reached on March 31, 2011.REGN Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.2% | +2.2% |
| 3 y3 years | -0.8% | +2.2% |
| 5 y5 years | -6.2% | +2.2% |
REGN Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +1.6% | -3.1% | +8.3% |
| 5 y | 5-year | -2.5% | +1.6% | -3.1% | +8.3% |
| alltime | all time | -13.5% | +214.4% | -12.9% | +144.6% |
Regeneron Pharmaceuticals Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 86.80%(+0.4%) |
| June 2024 | - | 86.46%(+0.3%) |
| Mar 2024 | - | 86.21%(+1.5%) |
| Dec 2023 | 86.16%(-1.2%) | 84.95%(-2.4%) |
| Sept 2023 | - | 87.02%(-0.2%) |
| June 2023 | - | 87.18%(+1.9%) |
| Mar 2023 | - | 85.53%(+1.6%) |
| Dec 2022 | 87.18%(+2.8%) | 84.17%(-5.6%) |
| Sept 2022 | - | 89.18%(-0.5%) |
| June 2022 | - | 89.60%(+3.8%) |
| Mar 2022 | - | 86.34%(+7.7%) |
| Dec 2021 | 84.83%(-2.3%) | 80.16%(-7.7%) |
| Sept 2021 | - | 86.87%(+0.4%) |
| June 2021 | - | 86.50%(-1.5%) |
| Mar 2021 | - | 87.82%(+2.8%) |
| Dec 2020 | 86.82%(-1.7%) | 85.43%(-3.0%) |
| Sept 2020 | - | 88.06%(+2.5%) |
| June 2020 | - | 85.89%(-2.5%) |
| Mar 2020 | - | 88.11%(+0.0%) |
| Dec 2019 | 88.33%(-3.9%) | 88.10%(+1.2%) |
| Sept 2019 | - | 87.07%(-4.1%) |
| June 2019 | - | 90.76%(+3.8%) |
| Mar 2019 | - | 87.46%(+21.0%) |
| Dec 2018 | 91.89%(-1.4%) | 72.28%(-22.6%) |
| Sept 2018 | - | 93.36%(-1.0%) |
| June 2018 | - | 94.30%(+2.1%) |
| Mar 2018 | - | 92.40%(-1.0%) |
| Dec 2017 | 93.24%(-0.6%) | 93.32%(+0.3%) |
| Sept 2017 | - | 93.05%(+0.1%) |
| June 2017 | - | 93.00%(-0.7%) |
| Mar 2017 | - | 93.62%(-0.3%) |
| Dec 2016 | 93.83%(+3.8%) | 93.91%(-2.6%) |
| Sept 2016 | - | 96.38%(+2.2%) |
| June 2016 | - | 94.31%(+4.0%) |
| Mar 2016 | - | 90.69%(+0.9%) |
| Dec 2015 | 90.43%(-2.5%) | 89.91%(-0.6%) |
| Sept 2015 | - | 90.41%(-0.8%) |
| June 2015 | - | 91.10%(+0.8%) |
| Mar 2015 | - | 90.35%(-2.4%) |
| Dec 2014 | 92.73%(+0.1%) | 92.59%(+0.3%) |
| Sept 2014 | - | 92.34%(-0.7%) |
| June 2014 | - | 93.03%(-0.0%) |
| Mar 2014 | - | 93.04%(+1.0%) |
| Dec 2013 | 92.62%(-1.3%) | 92.12%(-1.5%) |
| Sept 2013 | - | 93.54%(+2.4%) |
| June 2013 | - | 91.34%(-2.2%) |
| Mar 2013 | - | 93.39%(+0.7%) |
| Dec 2012 | 93.87%(-5.2%) | 92.72%(-2.7%) |
| Sept 2012 | - | 95.29%(+2.7%) |
| June 2012 | - | 92.82%(-2.0%) |
| Mar 2012 | - | 94.69%(-3.0%) |
| Dec 2011 | 99.05%(-0.5%) | 97.57%(-2.0%) |
| Sept 2011 | - | 99.56%(-0.1%) |
| June 2011 | - | 99.63%(-0.0%) |
| Mar 2011 | - | 99.66%(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | 99.54%(-0.0%) | 99.55%(-0.1%) |
| Sept 2010 | - | 99.65%(0.0%) |
| June 2010 | - | 99.65%(+0.3%) |
| Mar 2010 | - | 99.31%(-0.3%) |
| Dec 2009 | 99.56%(-0.1%) | 99.60%(0.0%) |
| Sept 2009 | - | 99.60%(+0.1%) |
| June 2009 | - | 99.52%(+0.0%) |
| Mar 2009 | - | 99.48%(+0.6%) |
| Dec 2008 | 99.61%(+14.3%) | 98.87%(-0.7%) |
| Sept 2008 | - | 99.55%(+3.9%) |
| Dec 2006 | 87.16%(+1.9%) | 95.84%(+19.1%) |
| Sept 2006 | - | 80.45%(-5.8%) |
| June 2006 | - | 85.41%(-4.9%) |
| Mar 2006 | - | 89.83%(+2.4%) |
| Dec 2005 | 85.56%(-6.2%) | 87.69%(+9.7%) |
| Sept 2005 | - | 79.96%(-10.9%) |
| June 2005 | - | 89.77%(+6.1%) |
| Mar 2005 | - | 84.63%(-8.6%) |
| Dec 2004 | 91.26%(+3.2%) | 92.62%(+22.9%) |
| Sept 2004 | - | 75.39%(-23.2%) |
| June 2004 | - | 98.14%(+1.8%) |
| Mar 2004 | - | 96.41%(+0.7%) |
| Dec 2003 | 88.39%(+25.3%) | 95.74%(+32.7%) |
| Sept 2003 | - | 72.15%(-25.7%) |
| June 2003 | - | 97.09%(+3.9%) |
| Mar 2003 | - | 93.43%(+44.0%) |
| Dec 2002 | 70.52%(+0.2%) | 64.86%(-13.6%) |
| Sept 2002 | - | 75.07%(+12.8%) |
| June 2002 | - | 66.58%(-10.7%) |
| Mar 2002 | - | 74.52%(+1.3%) |
| Dec 2001 | 70.38%(-4.6%) | 73.60%(-4.1%) |
| Sept 2001 | - | 76.75%(+13.9%) |
| June 2001 | - | 67.38%(+3.1%) |
| Mar 2001 | - | 65.34%(+20.2%) |
| Dec 2000 | 73.74%(-17.7%) | 54.34%(-34.7%) |
| Sept 2000 | - | 83.25%(-8.8%) |
| June 2000 | - | 91.31%(+28.7%) |
| Mar 2000 | - | 70.94%(-28.5%) |
| Dec 1999 | 89.57%(+3.0%) | 99.16%(+8.8%) |
| Sept 1999 | - | 91.15%(+14.4%) |
| June 1999 | - | 79.66%(+4.9%) |
| Mar 1999 | - | 75.93%(-3.8%) |
| Dec 1998 | 86.95%(-3.7%) | 78.95%(-10.2%) |
| Sept 1998 | - | 87.96%(-3.5%) |
| June 1998 | - | 91.11%(+5.8%) |
| Mar 1998 | - | 86.15%(+4.2%) |
| Dec 1997 | 90.33%(-5.4%) | 82.69%(-9.1%) |
| Sept 1997 | - | 91.01%(-1.5%) |
| June 1997 | - | 92.42%(+0.5%) |
| Mar 1997 | - | 91.94%(-147.3%) |
| Dec 1996 | 95.44%(-226.7%) | - |
| Sept 1993 | - | -194.44%(+29.6%) |
| Dec 1991 | -75.34%(+189.8%) | -150.00%(+469.9%) |
| Sept 1991 | - | -26.32%(-62.7%) |
| June 1991 | - | -70.59% |
| Dec 1990 | -26.00% | - |
FAQ
- What is Regeneron Pharmaceuticals annual gross profit margin?
- What is the all time high annual gross margin for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual gross margin year-on-year change?
- What is Regeneron Pharmaceuticals quarterly gross profit margin?
- What is the all time high quarterly gross margin for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly gross margin year-on-year change?
What is Regeneron Pharmaceuticals annual gross profit margin?
The current annual gross margin of REGN is 86.16%
What is the all time high annual gross margin for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual gross profit margin is 99.61%
What is Regeneron Pharmaceuticals annual gross margin year-on-year change?
Over the past year, REGN annual gross profit margin has changed by -1.02% (-1.17%)
What is Regeneron Pharmaceuticals quarterly gross profit margin?
The current quarterly gross margin of REGN is 86.80%
What is the all time high quarterly gross margin for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly gross profit margin is 99.66%
What is Regeneron Pharmaceuticals quarterly gross margin year-on-year change?
Over the past year, REGN quarterly gross profit margin has changed by +1.85% (+2.18%)